Exploring the Association between Diagnostic and Therapeutic Radiation and the Incidence of Vestibular Schwannoma: A Case–Control Study

Abstract

Introduction

Ionizing radiation is a known risk factor for various neoplasms, yet its link with vestibular schwannoma (VS) remains unclear. Given that VSs are benign tumors of the eighth cranial nerve, elucidating potential associations with radiation is of clinical interest. This study investigated the association between diagnostic and therapeutic head and neck radiation exposure and VS.

Methods

In a case–control design, we enrolled 137 patients with VS, matched by age and sex with 659 controls. Data were obtained through structured interviews, capturing sociodemographic factors and history of therapeutic head and neck radiation, as well as imaging examinations (X-ray, computed tomography [CT], and magnetic resonance [MR], excluding the last 2 years). Weighted distributions were used to account for up to six controls per case. We used conditional logistic regression to estimate odds ratios (ORs) and 95% confidence intervals (CIs).

Results

The mean age of participants was 53 ± 14.6 years, with 50.4% females. An initial significant association was observed between therapeutic radiation and VS (adjusted OR = 4.94, 95% CI: 2.49–7.98). However, excluding participants who recently underwent radiation therapy attenuated this association (adjusted OR = 2.32, 95% CI: 0.59–9.07; p = 0.22). No significant associations were found for diagnostic imaging (ORs of 1.04 [0.86–1.25], 1.18 [0.73–1.92], and 1.19 [0.57–2.49] for X-ray, CT, and MR, respectively).

Conclusion

Our findings do not support a significant relationship between either therapeutic or diagnostic head and neck radiation exposure and the risk of VS, once recent treatments are excluded. Additional large-scale studies are necessary to confirm these observations and to examine potential dose–response effects.

Keywords

vestibular schwannoma - diagnostic radiation - therapeutic radiation - case–control study - ionizing radiation

Publikationsverlauf

Eingereicht: 29. Dezember 2024

Angenommen: 25. März 2025

Accepted Manuscript online:
10. November 2025

Artikel online veröffentlicht:
25. November 2025

• References

• 1 Bondy ML, Scheurer ME, Malmer B. et al; Brain Tumor Epidemiology Consortium. Brain tumor epidemiology: consensus from the Brain Tumor Epidemiology Consortium. Cancer 2008; 113 (07) 1953-1968
• 2 Ostrom QT, Adel Fahmideh M, Cote DJ. et al. Risk factors for childhood and adult primary brain tumors. Neuro Oncol 2019; 21 (11) 1357-1375
• 3 Braganza MZ, Kitahara CM, Berrington de González A, Inskip PD, Johnson KJ, Rajaraman P. Ionizing radiation and the risk of brain and central nervous system tumors: A systematic review. Neuro Oncol 2012; 14 (11) 1316-1324
• 4 Durham AR, Tooker EL, Patel NS, Gurgel RK. Epidemiology and risk factors for development of sporadic vestibular schwannoma. Otolaryngol Clin North Am 2023; 56 (03) 413-420
• 5 Yonehara S, Brenner AV, Kishikawa M. et al. Clinical and epidemiologic characteristics of first primary tumors of the central nervous system and related organs among atomic bomb survivors in Hiroshima and Nagasaki, 1958-1995. Cancer 2004; 101 (07) 1644-1654
• 6 Corona AP, Ferrite S, Lopes Mda S, Rêgo MAV. Risk factors associated with vestibular nerve schwannomas. Otol Neurotol 2012; 33 (03) 459-465
• 7 Brackmann DE, Bartels LJ. Rare tumors of the cerebellopontine angle. Otolaryngol Head Neck Surg (1979) 1980; 88 (05) 555-559
• 8 Cardis E, Richardson L, Deltour I. et al. The INTERPHONE study: design, epidemiological methods, and description of the study population. Eur J Epidemiol 2007; 22 (09) 647-664
• 9 INTERPHONE Study Group. Acoustic neuroma risk in relation to mobile telephone use: Results of the INTERPHONE international case-control study. Cancer Epidemiol 2011; 35 (05) 453-464
• 10 Sadetzki S, Chetrit A, Jarus-Hakak A. et al. Cellular phone use and risk of benign and malignant parotid gland tumors–a nationwide case-control study. Am J Epidemiol 2008; 167 (04) 457-467
• 11 Li D, Yeung S-CJ, Hassan MM, Konopleva M, Abbruzzese JL. Antidiabetic therapies affect risk of pancreatic cancer. Gastroenterology 2009; 137 (02) 482-488
• 12 Walker EJ, Ko AH, Holly EA, Bracci PM. Metformin use among type 2 diabetics and risk of pancreatic cancer in a clinic-based case-control study. Int J Cancer 2015; 136 (06) E646-E653
• 13 Dankner R, Boffetta P, Balicer RD. et al. Time-dependent risk of cancer after a diabetes diagnosis in a cohort of 2.3 million adults. Am J Epidemiol 2016; 183 (12) 1098-1106
• 14 Marinelli JP, Beeler CJ, Carlson ML, Caye-Thomasen P, Spear SA, Erbele ID. Global incidence of sporadic vestibular schwannoma: A systematic review. Otolaryngol Head Neck Surg 2022; 167 (02) 209-214
• 15 Marinelli JP, Grossardt BR, Lohse CM, Carlson ML. Prevalence of sporadic vestibular schwannoma: Reconciling temporal bone, radiologic, and population-based studies. Otol Neurotol 2019; 40 (03) 384-390
• 16 Marinelli JP, Lohse CM, Carlson ML. Incidence of vestibular schwannoma over the past half-century: A population-based study of Olmsted County, Minnesota. Otolaryngol Head Neck Surg 2018; 159 (04) 717-723
• 17 Koo M, Lai J-T, Yang EY-L, Liu T-C, Hwang J-H. Incidence of vestibular schwannoma in Taiwan from 2001 to 2012: A population-based National Health Insurance study. Ann Otol Rhinol Laryngol 2018; 127 (10) 694-697
• 18 Reznitsky M, Petersen MMBS, West N, Stangerup S-E, Cayé-Thomasen P. Epidemiology of vestibular schwannomas - prospective 40-year data from an unselected national cohort. Clin Epidemiol 2019; 11: 981-986
• 19 Kleijwegt M, Ho V, Visser O, Godefroy W, van der Mey A. Real incidence of vestibular schwannoma? Estimations from a national registry. Otol Neurotol 2016; 37 (09) 1411-1417
• 20 Marinelli JP, Lohse CM, Grossardt BR, Lane JI, Carlson ML. Rising incidence of sporadic vestibular schwannoma: True biological shift versus simply greater detection. Otol Neurotol 2020; 41 (06) 813-847
• 21 Schüz J, Pirie K, Reeves GK, Floud S, Beral V. Million Women Study Collaborators. Cellular telephone use and the risk of brain tumors: Update of the UK million women study. J Natl Cancer Inst 2022; 114 (05) 704-711
• 22 Corona AP, Oliveira JC, Souza FP, Santana LV, Rêgo MAV. Risk factors associated with vestibulocochlear nerve schwannoma: Systematic review. Braz J Otorhinolaryngol 2009; 75 (04) 593-615
• 23 Pettersson D, Mathiesen T, Prochazka M. et al. Long-term mobile phone use and acoustic neuroma risk. Epidemiology 2014; 25 (02) 233-241
• 24 Benson VS, Pirie K, Schüz J, Reeves GK, Beral V, Green J. Authors' response to: The case of acoustic neuroma: comment on mobile phone use and risk of brain neoplasms and other cancers. Int J Epidemiol 2014; 43 (01) 275
• 25 Berkowitz O, Iyer AK, Kano H, Talbott EO, Lunsford LD. Epidemiology and environmental risk factors associated with vestibular schwannoma. World Neurosurg 2015; 84 (06) 1674-1680
• 26 Schoemaker MJ, Swerdlow AJ, Auvinen A. et al. Medical history, cigarette smoking and risk of acoustic neuroma: an international case-control study. Int J Cancer 2007; 120 (01) 103-110
• 27 Benson VS, Green J, Pirie K, Beral V. Cigarette smoking and risk of acoustic neuromas and pituitary tumours in the Million Women Study. Br J Cancer 2010; 102 (11) 1654-1656
• 28 Chen M, Fan Z, Zheng X, Cao F, Wang L. Risk factors of acoustic neuroma: Systematic review and meta-analysis. Yonsei Med J 2016; 57 (03) 776-783
• 29 Auvinen A, Cardis E, Blettner M. et al; INTERPHONE study group. Diagnostic radiological examinations and risk of intracranial tumours in adults-findings from the Interphone Study. Int J Epidemiol 2022; 51 (02) 537-546
• 30 Hu J, Little J, Xu T. et al. Risk factors for meningioma in adults: a case-control study in northeast China. Int J Cancer 1999; 83 (03) 299-304
• 31 Preston-Martin S, Thomas DC, Wright WE, Henderson BE. Noise trauma in the aetiology of acoustic neuromas in men in Los Angeles County, 1978-1985. Br J Cancer 1989; 59 (05) 783-786
• 32 Han Y-Y, Berkowitz O, Talbott E, Kondziolka D, Donovan M, Lunsford LD. Are frequent dental X-ray examinations associated with increased risk of vestibular schwannoma?. J Neurosurg 2012; 117: 78-83
• 33 Rodvall Y, Ahlbom A, Pershagen G, Nylander M, Spännare B. Dental radiography after age 25 years, amalgam fillings and tumours of the central nervous system. Oral Oncol 1998; 34 (04) 265-269
• 34 Ryan P, Lee MW, North B, McMichael AJ. Amalgam fillings, diagnostic dental x-rays and tumours of the brain and meninges. Eur J Cancer B Oral Oncol 1992; 28B (02) 91-95
• 35 Blettner M, Schlehofer B, Samkange-Zeeb F, Berg G, Schlaefer K, Schüz J. Medical exposure to ionising radiation and the risk of brain tumours: Interphone study group, Germany. Eur J Cancer 2007; 43 (13) 1990-1998
• 36 Phillips LE, Frankenfeld CL, Drangsholt M, Koepsell TD, van Belle G, Longstreth Jr WT. Intracranial meningioma and ionizing radiation in medical and occupational settings. Neurology 2005; 64 (02) 350-352
• 37 Ron E, Modan B, Boice Jr JD. et al. Tumors of the brain and nervous system after radiotherapy in childhood. N Engl J Med 1988; 319 (16) 1033-1039